These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21886387)

  • 1. Hematologic changes in visceral leishmaniasis/kala azar.
    Varma N; Naseem S
    Indian J Hematol Blood Transfus; 2010 Sep; 26(3):78-82. PubMed ID: 21886387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Hematological Features of Visceral Leishmaniasis at Mymensingh Medical College Hospital.
    Malek MS; Robi IH; Islam MS; Kabir MA; Uddin MZ; Sumon SM; Siddiqui NI
    Mymensingh Med J; 2020 Oct; 29(4):879-886. PubMed ID: 33116091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
    Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
    Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the recent clinical isolates of Indian Kala-azar patients by RAPD-PCR method.
    Khanra S; Bandopadhyay SK; Chakraborty P; Datta S; Mondal D; Chatterjee M; Naskar K; Roy S; Manna M
    J Parasit Dis; 2011 Oct; 35(2):116-22. PubMed ID: 23024491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased
    Cloots K; Marino P; Burza S; Gill N; Boelaert M; Hasker E
    Front Cell Infect Microbiol; 2021; 11():604117. PubMed ID: 33777831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral Leishmaniasis (Kala-Azar): A Triumph Against a Trickster Disease.
    Pasha F; Saleem S; Nazir T; Tariq J; Qureshi K
    Cureus; 2022 Jun; 14(6):e25698. PubMed ID: 35812632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Haematological Parameters Associated With Visceral Leishmaniasis in Bangladeshi Individuals.
    Sarkar SR; Ray NC; Khan ER; Haque N; Hossain MA; Paul SK; Noiri E; Matsumoto Y; Sanjoba C
    Mymensingh Med J; 2018 Jul; 27(3):496-503. PubMed ID: 30141437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated intravascular coagulation as an unusual presentation of Kala-azar: report of two cases.
    Mishra P; Dixit A; Chatterjee T; Bhattacharya M; Bhattacharya J; Dutta P; Mahapatra M; Pati HP; Choudhry VP; Saxena R
    Scand J Infect Dis; 2004; 36(6-7):519-21. PubMed ID: 15307590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rare Presentation of Leishmaniasis.
    Prajapati R; Kumar A; Sharma P; Singla V; Bansal N; Dhawan S; Arora A
    J Clin Exp Hepatol; 2016 Jun; 6(2):146-8. PubMed ID: 27493461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S; Bajracharya BL; Baral MR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
    Singh S ; Kumar J; Singh R; Dwivedi SN
    Int J Infect Dis; 2000; 4(4):203-8. PubMed ID: 11231183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
    Zijlstra EE
    Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmaniasis in Sudan. Visceral leishmaniasis.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kala-Azar and leukemia: A rare association.
    Bay A; Aktekin EH; Ekşi F; Özcan M
    Turk Pediatri Ars; 2018 Mar; 53(1):45-47. PubMed ID: 30083074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
    Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
    J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kala-Azar: A Case Report.
    Jancar N; Sousa Gonçalves F; Duro J; Pinto I; Oliveira T; Aguiar P
    Cureus; 2023 Feb; 15(2):e34864. PubMed ID: 36923201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post kala-azar dermal leishmaniasis: A threat to elimination program.
    Gedda MR; Singh B; Kumar D; Singh AK; Madhukar P; Upadhyay S; Singh OP; Sundar S
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008221. PubMed ID: 32614818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of co-infection of Leptomonas in visceral leishmaniasis in India.
    Selvapandiyan A; Ahuja K; Puri N; Krishnan A
    Parasitology; 2015 Dec; 142(14):1657-62. PubMed ID: 26492813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.
    Dey A; Singh S
    Infect Genet Evol; 2007 Mar; 7(2):219-22. PubMed ID: 17027344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.